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ABSTRACT
Fibroblast growth factor (FGF) is among the most com-
mon growth factors used in cultures to maintain self-
renewal and proliferative capabilities of a variety of stem
cells, including neural stem cells (NSCs). However, the
molecular mechanisms underlying the control by
FGF have remained elusive. Studies on mutant mice of
FGF receptor substrate 2a (FRS2a), a central mediator
for FGF signaling, combined with FRS2a knockdown
or gain-of-function experiments, allowed us to dissect the
role of FGF signaling for the self-renewal and prolifera-
tion of NSCs and to provide novel molecular mechanisms
for them. We identiﬁed Hes1 as a novel self-renewal target
of FGF-signaling. Quantitatively different levels of
Erk activation mediated by FRS2a may regulate self-
renewal of NSCs and proliferation of neural stem/progeni-
tor cells (NSPCs); low levels of Erk activation are sufﬁ-
cient for the former, however, higher levels are required
for maximum activity of the latter. Thus, FRS2a ﬁne-tunes
the FGF-signaling to control qualitatively different
biological activities, self-renewal at least partly through
Hes1 versus proliferation of NSPCs. STEM CELLS 2010;28:
1660–1672
Disclosure of potential conﬂicts of interest is found at the end of this article.
INTRODUCTION
Fibroblast growth factor (FGF) signaling mediates diverse cel-
lular responses during embryonic development and plays criti-
cal roles in the physiological and pathological processes of
the adult organism [1]. Particularly, FGF signaling plays a
crucial role in the self-renewal and proliferation of various
stem cells such as human embryonic stem cells, human-
induced pluripotent stem cells, trophoblast stem cells, and
neural stem cells (NSCs) [2, 3]. Moreover, it has been
recently reported that cancer stem cells derived from vari-
ous types of human tissues, such as brain and breast tis-
sues, can be cultured in vitro in the presence of FGF [3].
Many studies indicate that FGF signaling has critical func-
tions in both self-renewal and proliferation of neural stem/
progenitor cells (NSPCs) in vitro and in vivo [4–7]. The
molecular mechanisms by which FGF controls the two dis-
tinct processes, that is, the self-renewal and proliferation of
stem cells, are still unclear. The lack of such knowledge
prevents the development of appropriate methods to culti-
vate stem cells with suitable qualities, which are critical to
regenerative medicine such as cell replacement therapy for
disease-damaged tissues or organs.
The membrane-linked docking/scaffolding adaptor FGF
receptor substrate 2 (FRS2)-a acts as a central mediator for
FGF signaling [1, 8-11]. Once stimulated by FGF, FRS2a
becomes tyrosine-phosphorylated and creates two speciﬁc
binding sites for Shp2, an SH2 domain-containing tyrosine
phosphatase and four binding sites for the adaptor protein,
Grb2, leading to activation of Ras-Erk pathway [12, 13]. We
previously examined contribution of each site for FGF-
induced activation of Erk by exogenously expressing wild-
type FRS2a or its mutants in Frs2a
 /  mouse embryonic
ﬁbroblasts [13]. Strong activation of Erk is observed in cells
expressing the wild-type FRS2a or FRS2a-4F, in which tyro-
sine residues of Grb2-binding sites are replaced with phenyl-
alanine, though the cells expressing FRS2a-4F shows slightly
lower levels of Erk activity than wild-type. FRS2a-2F, in
which tyrosine residues of Shp2-binding sites are replaced
with phenylalanine, shows more reduced levels of activation
of Erk and FRS2a-6F, a combined mutant of both Grb2- and
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the Shp2-binding sites in FRS2a have a primary role in the
activation of Erk, whereas the Grb2-binding sites have a sec-
ondary role in the activation of Erk [13–15].
Frs2a is ubiquitously expressed during development [16].
To analyze the functions of FRS2a, we previously constructed
a Frs2a-knockout mouse and two knockin mice that express a
mutant form of FRS2a whose tyrosine residues of Grb2
(Frs2a
4F mutant)- or Shp2 (Frs2a
2F mutant)-binding sites are
replaced with phenylalanine and demonstrated its critical
functions in multiple developmental processes that are de-
pendent on FGF-signaling. Embryos of the Frs2a-knockout
mouse have defects in the FGF4-dependent maintenance of
trophoblast stem cells and shows developmental retardation,
resulting in embryonic lethality by E8 [12]. Frs2a
4F/4F mice
can survive as adults and show no gross morphological
defects except for eyelid developmental defects that arise with
low penetrance [15]. Frs2a
2F/2F mice display multiple devel-
opmental defects along with perinatal death. Embryos of
Frs2a
2F/2F mice lack carotid bodies [17], have defective eye
development and show anophthalmia or microphthalmia [15].
The expression of Frs2a is particularly strong in the ven-
tricular zone (VZ) of the developing cortex, where radial glial
cells (embryonic NSPCs) are localized [16]. In addition, Fgfs,
together with the genes for their receptors (Fgfrs), are also
expressed in the VZ [18–21]. By analyzing the Frs2a
2F mu-
tant mice, we previously demonstrated that these sites are
required for the proliferation of neural progenitor cells but are
dispensable for the self-renewal of NSCs both in vivo and in
vitro [22]. However, previous studies indicate that FGF sig-
naling is required for the self-renewal of NSCs [23, 24].
Given that FRS2a is a central mediator of FGF signaling, we
decided to further explore the function of FRS2a in NSCs.
In this study, we performed gain-of- and loss of-function anal-
ysis of FRS2a both in vitro and in vivo. These analyses showed
that the quantitative regulation of Erk activation levels by FRS2a
is important not only for the proliferation of NSPCs but also for
the self-renewal of NSCs. Moreover, we identiﬁed Hes1 as a novel
target of FGF-signaling for the self-renewal of NSCs. Our results
suggest that FRS2a stands as a central player in the regulation of
the delicate balance between the numbers of NSCs and progenitor
cells to maintain proper homeostatic number of neural cells in cul-
tural systems and cortical development.
MATERIALS AND METHODS
Cell Culture
Primary neurospheres were established from the telencephalons
of E12.5 or E14.5 embryos. Telencephalons were dissociated by
trituration. Cells were then cultured in basal serum-free medium
[22] containing 20 ng/ml FGF2 (PEPROTECH, Rocky Hill/NJ,
http://www.peprotech.com/) or 20 ng/ml epidermal growth factor
(EGF; TOYOBO, Osaka/Japan, http://www.toyobo.co.jp/e/) for
4–5 days. The resulting primary neurospheres were dissociated,
either infected with virus or not, and then cultured in the pres-
ence of the same growth factor as the primary neurospheres for
7–9 days. The resulting secondary neurospheres were dissoci-
ated, and Green Fluorescent Protein (GFP)- or ZsGreen-positive
(virus infected) cells were sorted by Fluorescence Activated Cell
Sorting (FACS) (Beckton Dickinson FACSAria) and plated into
96-well plates (Corning, Corning/NY, http://www.corning.com/
index.aspx). The cells were cultured again in the presence of the
same growth factor as the secondary neurospheres, unless noted,
for 9–12 days. Next, the size and number of tertiary neurospheres
were determined. The Mek inhibitors U0126 (Calbiochem,
Darmstadt/Germany, http://www.merck-chemicals.jp/life-science-
research/calbiochem/japanese/c_PmSb.s1ON3EAAAEj0uBXhFCU),
PD98059 (Cell Signaling), and c-secretase inhibitor DAPT (N-[N-
(3,5-diﬂuorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester)
(Calbiochem) were dissolved in dimethyl sulfoxide (DMSO) and
added to the culture medium at indicated concentrations. Half of
the culture medium with inhibitors was changed every day. For
adherent culture of NSPCs, cells were seeded to a culture dish
precoated with 15 lg/ml poly-(L-ornithine) (Sigma) and 1 lg/ml
ﬁbronectin (Sigma, St. Louis, MO, http://www.sigmaaldrich.com/
united-states.html).
Statistical Analysis
Data in the graphs are represented as mean 6 SD. The statis-
tical signiﬁcance was assessed with Student’s t-test or
Welch’s t-test according to the variance between the two sam-
ples. Statistically signiﬁcant differences are indicated with an
asterisk (p < .05) or double asterisks (p < .01) in the ﬁgures.
RESULTS
Overexpression of FRS2a Promotes FGF2-Induced
Proliferation and Self-Renewal of NSPCs In Vitro
It has been shown that NSPCs located in the telencephalon
can be stimulated to proliferate in response to FGF2 or EGF
stimulation and form spherical cell clusters called neuro-
spheres in vitro [25]. The neurosphere cells are composed of
heterogenous cell populations, including stem cells and multi-
potent progenitor cells [26]. Because self-renewing NSCs are
capable of reforming new neurospheres and each neurosphere
is derived from a single NSC, the frequency of neurosphere
formation corresponds to the self-renewing capacity of the
NSCs in the original neurospheres [22, 27, 28].
We ﬁrst performed a gain-of-function analysis of FRS2a in
vitro. We used wild-type FRS2a and two mutants: FRS2a-6F
and FRS2a-8V. FRS2a-6F has all six tyrosine phosphorylation
sites replaced by phenylalanine residues. FRS2a-6F does not
interact with Shp2 or Grb2, and the introduction of an FRS2a-
6F-expressing vector into FRS2a-deﬁcient mouse embryonic
ﬁbroblasts could not rescue the activation of Erk in these cells
in response to FGF [13, 14]. The other FRS2a mutant FRS2a-
8V has eight threonine phosphorylation sites replaced by valine
residues, and it is thought to act as a dominant active form of
FRS2a, which is sensitized to FGF stimulation due to the lack
of negative regulatory phosphorylation sites [29].
We obtained NSPCs from the telencephalons of embry-
onic day (E) 14.5 mouse embryos and cultured them in the
presence of FGF2 or EGF to obtain primary neurospheres.
The primary neurospheres were dissociated to single cells and
transduced with retroviral expression vectors encoding wild-
type FRS2a or its mutant forms, FRS2a-6F or FRS2a-8V, to-
gether with GFP and the cells were cultured in the presence
of FGF2 or EGF to form secondary neurospheres. The sec-
ondary neurospheres were dissociated, and cells expressing
GFP were sorted by FACS; these sorted cells were cultured
again in the presence of FGF2 or EGF to form tertiary
neurospheres.
When NSPCs were cultured in the presence of FGF2,
cells expressing FRS2a or FRS2a-8V, but not FRS2a-6F,
formed signiﬁcantly larger tertiary neurospheres than did con-
trol neurospheres transduced with an empty vector (Fig. 1A).
In contrast, when NSPCs were cultured in the presence of
EGF, the expression of FRS2a or its mutant forms had no
effect on the size of neurospheres (Fig. 1B). Interestingly, the
expression of wild-type FRS2a or FRS2a-8V, but not FRS2a-
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induced tertiary neurosphere formation (Fig. 1C) but not that
of EGF-induced neurosphere formation (Fig. 1D). We
obtained similar results using NSPCs from E12.5 telencepha-
lons (Fig. 1E and Supporting Information Fig. 1). These
results suggest that the FGF2-induced tyrosine phosphoryla-
tion of FRS2a is important not only for the proliferation of
NSPCs but also for the self-renewal of NSCs in vitro. To con-
ﬁrm this further, we passaged FGF2-induced secondary neuro-
spheres and then cultured the NSPCs in the presence of EGF.
The frequency of EGF-induced tertiary neurosphere formation
was increased when using FRS2a or FRS2a-8V, but not
FRS2a-6F, was expressed (Fig. 1F). Expression of FRS2a or
FRS2a-8V had no effect on the formation of EGF-induced
tertiary neurospheres when EGF-induced secondary neuro-
spheres were used (Fig. 1D). This result indicates that the
expression of FRS2a or FRS2a-8V enriched the number of
self-renewing NSCs in each neurosphere induced by FGF2
but not by EGF.
To conﬁrm the expression of FRS2a protein in neuro-
sphere cells, we performed western blotting. Strong expres-
sion of FRS2a was observed in cells expressing the wild-type
or mutant forms (Fig. 1G). Both wild-type FRS2a and
FRS2a-6F showed a strong shift in electrophoretic mobility in
response to FGF2 (Fig. 1G). Consistent with the notion that
the shift is largely caused by the phosphorylation of threo-
nines in FRS2a by activated Erk, FRS2a-8V showed only a
slight shift [29]. Western blotting was used to examine the
activation of components of the FGF signaling pathways
downstream of FRS2a in NSPCs expressing wild-type or mu-
tant forms of FRS2a in response to FGF2. Stronger activation
of Erk or Akt was observed in cells overexpressing FRS2a or
FRS2a-8V after stimulation with FGF2 compared with
FRS2a-6F-expressing cells or control cells (Fig. 1H, 1I).
Enhanced Akt activation is consistent with a previous report
that Grb2-binding to Gab1 contributes to activation of
Akt [13]. We also evaluated the activation of Shp2 and Gab1
by immunoblotting with anti-phospho-Shp2 and anti-phospho-
Gab1 antibodies, respectively. Activation of Shp2 and
Gab1 was enhanced in cells expressing wild-type FRS2a or
FRS2a-8V compared with control cells or cells expressing 6F
(Fig. 1G).
Overexpression of FRS2a Promotes FGF2-Induced
Proliferation and Self-Renewal of NSPCs In Vivo
To examine the function of FRS2a in the self-renewal of
NSCs in vivo, we overexpressed wild-type FRS2a or its mu-
tant forms in the developing mouse cortex using a retroviral
expression system. We injected retrovirus into the telence-
phalic lateral ventricles of E12.5 mouse embryos in utero and
then sacriﬁced them at E15.5. At these stages, NSPCs are nor-
mally localized at the VZ/subventricular zone (SVZ) and gen-
erate neurons, and those neurons migrate out of the VZ/SVZ
through the intermediate zone (IZ) to settle at the cortical
plate (CP) [30]. Immunohistochemistry of the viral GFP
marker in cortical sections showed that a large number of
control or FRS2a-6F-expressing cells migrate out of the VZ/
Figure 1. Overexpression of FRS2a promotes FGF2-induced proliferation and self-renewal of neural stem/progenitor cells (NSPCs) in vitro.
(A–E): NSPCs were infected with retrovirus and cultured in the presence of FGF2 (A, C) or EGF (B, D). Then, the diameter (A, B) or number
(C, D) of resulting neurospheres was determined. A minus ( ) sign indicates that the virus was not infected. Scale bars ¼ 500 lm (E).
(F): EGF-induced tertiary neurospheres were produced from FGF2-induced secondary neurospheres, and the number of neurospheres was deter-
mined. Experiments were performed at least two times with similar results. (G–I): Neurospheres were starved and then stimulated with FGF2.
Then, the lysates were subjected to immunoblotting. The arrow in (G) indicates nonspeciﬁc bands. Abbreviations: EGF, epidermal growth factor;
FGF, ﬁbroblast growth factor; FRS2a, FGF receptor substrate 2a.
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FRS2a- or FRS2a-8V-expressing cells remained in the VZ/
SVZ, and the number of cells in the IZ/CP was decreased
compared with controls (Fig. 2C–2E). These results imply
that the expression of FRS2a or FRS2a-8V, but not FRS2a-
6F, represses the differentiation of NSPCs.
To examine the identity of virus-infected cells, we per-
formed double-immunostaining against GFP and TuJ1 (a neu-
ronal marker) or Musashi-1 (a NSPC marker). This analysis
showed that the overexpression of FRS2a or FRS2a-8V, but
not FRS2a-6F, increased the ratio of NSPCs to neurons (Fig.
2F–2N).
To conﬁrm that cells expressing FRS2a or FRS2a-8V are
‘‘bona ﬁde’’ NSCs, we examined whether they express nestin,
another marker of NSCs, and undergo interkinetic nuclear
migration (INM), a cell cycle-dependent somal translocation
process unique to radial glial cells [31]. During the S-phase,
the soma of radial glial cells is located at the basal (abventric-
ular) side of VZ, but descends toward the apical (ventricular)
surface during the G2 phase. The cell body is present at the
ventricular surface during the M phase, and ascends basally
during the G1 phase. We coinjected vectors expressing
FRS2a or FRS2a-8V together with GFP into E13.5 cortex and
performed in utero electroporation, and then sacriﬁced the
embryos at E15.5. BrdU was administered 30 minutes or 12
hours before sacriﬁce to label cells in the S-phase or mainly
the G1 phase, respectively [32]. Then, cortical sections of the
embryos were subjected to double-immunostaining with anti-
bodies against GFP and nestin or BrdU. This analysis showed
that most cells in the VZ expressing FRS2a or FRS2a-8V
were nestin-positive (95.7% 6 5.4% of cells expressing
FRS2a among a total of 691 cells counted in 22 randomly
selected areas; 97.9% 6 5.5% of cells expressing FRS2a-8V
among a total of 717 cells counted in 26 randomly selected
areas; Fig. 3A). Although cell bodies expressing FRS2a or
FRS2a-8V were present at the basal side of VZ when BrdU
was administered 30 minutes before sacriﬁce, many of them
were located at the apical side when BrdU was administered
12 hours before sacriﬁce (Fig. 3B and 3C). These results
strongly suggest that cells expressing FRS2a or FRS2a-8V
underwent INM and remained bona ﬁde NSCs.
Together, our results raise the possibility that FGF signal-
ing mediated by tyrosine phosphorylation of FRS2a represses
NSPC differentiation and thereby promotes the self-renewal
of NSPCs in vivo.
Grb2-binding sites of FRS2a Are Required for the
Maximum Proliferation of NSPCs, But Are
Dispensable for the Self-Renewal of NSCs
We have previously demonstrated that the Shp2-binding sites
of FRS2a are dispensable for the self-renewal of NSCs [22];
therefore, we next analyzed the function of the Grb2-binding
sites of FRS2a using an Frs2a
4F mutant mouse in which phe-
nylalanine replaces four tyrosine residues in the Grb2-binding
sites. Although FGF2-induced secondary neurospheres from
the telencephalons of E14.5 Frs2a
4F mutant embryos were
smaller than those of wild-type embryos (Fig. 4A), the
Figure 2. Overexpression of FRS2a represses the differentiation of neural stem/progenitor cells (NSPCs) in the developing cortex. (A–D): Ret-
roviruses were injected in utero into the telencephalic ventricles at E12.5. The embryos were then sacriﬁced at E15.5, and cortical sections were
immunostained against GFP (green). (E): Quantiﬁcation of the data presented in (A–D). In each condition, at least 183 cells were counted in 10
randomly selected areas. (F–M): Cortical sections of embryo infected with viruses were double-immunostained against GFP (green) and Musa-
shi-1 (magenta) (F–I), or TuJ1 (magenta) (J–M). Nuclear staining is shown in blue. The panels (H), (I), (L), and (M) are higher magniﬁcations
of the regions indicated by rectangles in (F), (G), (J), and (K), respectively. (N): Quantiﬁcation of the data presented in (F–M). In each condi-
tion, at least 64 cells were counted in 10 randomly selected areas. Scale bars ¼ 50 lm. Abbreviations: CP, cortical plate; GFP, Green Fluorescent
Protein; FRS2a, FGF receptor substrate 2a; IZ, intermediate zone; SVZ, subventricular zone; VZ, ventricular zone.
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cantly different (Fig. 4B). Thus, the self-renewal ability of
NSCs from Frs2a
4F/4F mutant mice appears to be normal,
although the proliferation of mutant NSPCs was slightly
decreased in vitro.
Immunohistochemical analysis of the telencephalons of
E14.5 embryos using anti-phospho-histone H3 (pH3) anti-
body, an M-phase marker, showed that the mitotic activity of
the mutant telencephalons was normal in the VZ, where radial
glial cells divide. Cell division in the E14.5 SVZ of the cortex
but not of the ganglionic eminence, where intermediate pro-
genitor cells divide [22, 33, 34], was slightly reduced (Fig.
4C–4G). Intermediate progenitor cells are derived from
radial glial cells and are committed to neuronal cells. This
result conﬁrms that the self-renewal ability of NSCs from
Frs2a
4F/4F mutant mice appears to be normal, although the
proliferation of mutant NSPCs was slightly decreased.
In response to FGF2 stimulation, mutant NSPCs showed
moderately decreased Erk activation compared with wild-type
cells (Fig. 4H). However, the activation of Akt was not
affected in the mutant NSPCs. In addition, western blotting
using lysates of E11.5 brain tissue showed that Erk activation,
but not the Akt activation level, was moderately decreased in
mutant brains (Fig. 4I). Tyrosine phosphorylation of one of
the Grb2-binding sites of FRS2a, tyrosine-196, was reduced
in mutant brains, conﬁrming that the mutant lacks these sites.
Thus, although the proliferation and Erk activation of
Frs2a
4F NSPCs are moderately impaired, the self-renewal
ability of the mutant NSCs appears to be normal both in vivo
and in vitro.
Erk Activation via FRS2a Is Required for the Full
Activity of FGF-Induced Self-Renewal of NSCs
It seems paradoxical that the data from the gain-of-function
experiments suggest that tyrosine phosphorylation of FRS2a
enhances the self-renewal of NSCs; however, the loss of the
Shp2-binding sites [22] or the Grb2-binding sites (Fig. 4B, 4G)
of FRS2a does not affect the self-renewal ability of NSCs.
Although Erk activation, but not Akt activation, was moderately
r e d u c e di nb o t ht h eFrs2a
4F (Fig. 4H, 4I) and Frs2a
2F mutants
[22], Erk activation via either the Shp2- or Grb2-binding sites
of FRS2a appears to be sufﬁcient for the self-renewal of NSCs.
If both of these sites are lost, however, Erk activation may be
severely diminished, and the self-renewal ability of NSCs may
be compromised. To test this possibility, we blocked Frs2a
translation in NSPCs with short hairpin (sh) RNA-expressing
retroviral vectors. shRNAs for Frs2a (shFrs2a-1 or shFrs2a-2)
effectively downregulated the expression of FRS2a (Fig. 5A).
Then, we transduced the retroviral vectors into NSPCs from
E14.5 telencephalons and cultured them in the presence of
FGF2. We found that cells expressing shFrs2a-1 or shFrs2a-2
formed smaller and fewer secondary neurospheres than cells
expressing control shRNA (Fig. 5B, 5C). Furthermore, neuro-
spheres with decreased Frs2a expression showed strongly
reduced activation of Erk in response to FGF2 stimulation, but
the activation of Akt was not affected (Fig. 5D, 5E). These
Figure 3. Cells expressing
FRS2a or FRS2a-8V show ra-
dial glial properties. (A): Most
GFP-positive cells (green),
which express FRS2a or FRS2a-
8V, also expressed nestin (ma-
genta), as indicated by the
arrowheads. Scale bar ¼ 50 lm.
(B): The cell bodies of most
GFP-positive cells in the S-
phase (30 minutes after BrdU
administration), identiﬁed by
BrdU signals (magenta), were
located at the basal half of VZ
(arrowhead). In contrast, the cell
bodies of GFP-positive cells in
the G1 phase (12 hours after
BrdU administration) were pres-
ent at both the basal and apical
(arrow) halves of VZ. Scale bar
¼ 10 lm. (C): Quantiﬁcation of
the data presented in (B). About
300 cells were counted in each
condition in 20–32 randomly
selected areas. Abbreviations:
BrdU, Bromodeoxyuridine;
GFP, Green Fluorescent Protein;
FRS2a, FGF receptor substrate
2a; VZ, ventricular zone.
1664 FRS2a-Erk Axis Regulates Neural Stem Cellsresults suggest that the FRS2a-Erk axis, but not the FRS2a-Akt
axis, contributes to the self-renewal of NSCs and to the efﬁcient
proliferation of NSPCs in response to FGF2.
To examine the relationship between the Erk activation
level and self-renewal as well as the proliferation of NSPCs,
we treated NSPCs from E14.5 mouse telencephalons with dif-
ferent doses of a MEK inhibitor U0126. We found that Erk
activation was decreased in a dose-dependent manner (Fig.
5F). Next, we cultured them in the presence of FGF2. The
resulting primary neurospheres were dissociated and cell num-
bers were counted; then, the same number of NSPCs were
cultured again to form secondary neurospheres. Our results
demonstrated that the number of cells and the number of neu-
rospheres both were decreased with treatment with U0126 in
a dose-dependent manner (Fig. 5G). It thus appears that there
is a close correlation between the activation levels of Erk and
the self-renewal of NSCs as well as the proliferation of
NSPCs. Moreover, we noticed that the number of cells was
Figure 4. The Grb2-binding sites of FRS2a are required for the maximum levels of the proliferation of neural stem/progenitor cells, but are dis-
pensable for the self-renewal of neural stem cells. (A, B): The diameter of the ﬁbroblast growth factor 2 (FGF2)-induced secondary neurospheres
derived from E14.5 telencephalon was slightly decreased in the mutant (A). The number of the secondary neurospheres was not signiﬁcantly dif-
ferent (B). Experiments were performed three times with similar results. (C–F): The cortex or GE of E14.5 embryos was immunostained with
anti-pH3 antibody (red). Scale bar ¼ 50 lm. (G) Quantiﬁcation of the data presented in (C–F). In each condition, at least 280 cells positive for
phospho-histone H3 in VZ or SVZ were counted in 36 randomly selected areas. (H): Neurospheres were starved and then stimulated with FGF2.
The signal intensities of pErk1/2 and Erk1/2 were quantiﬁed, and represented as the relative activity of pErk against Erk1/2 (right panel).
(I): Brains of E11.5 embryos were lysed and subjected to immunoblotting. Two independent samples are indicated for each genotype. Abbrevia-
tions: GE, ganglionic eminence; FRS2a, FGF receptor substrate 2a; LV, lateral ventricle; SVZ, subventricular zone; VZ, ventricular zone.
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same dose of U0126. When we used U0126 at lower doses,
less than 0.7 lM, the number of cells was moderately sup-
pressed, while the number of neurospheres was not signiﬁ-
cantly changed (Fig. 5H).
To further examine the correlation between Erk activation,
self-renewal, and proliferation, we used PD98058, another
MEK inhibitor. PD98059 moderately inhibited Erk activation
in a dose-dependent manner, but it was less effective than
U0126 (Supporting Information Fig. 3A and Fig. 5F). Next,
we treated NSPCs from E14.5 mouse telencephalons with dif-
ferent doses of PD98059 and cultured them in the presence of
FGF2. The resulting primary neurospheres were dissociated
and cell numbers were counted; then, the same numbers of
NSPCs were cultured again to form secondary neurospheres.
As a result, although the numbers of cells were decreased in a
dose-dependent manner, there was little change in the number
of neurospheres at any dose (Supporting Information Fig. 3B).
It appears that cell proliferation was inhibited in correla-
tion with the moderately reduced levels of Erk activity; how-
ever, the inhibition levels of Erk activation by U0126 at low
doses or by PD98059 were not sufﬁcient for the inhibition of
self-renewing activity in this assay condition.
Therefore, a low level of Erk activation appears to be suf-
ﬁcient for the self-renewal of NSCs, whereas a high level of
Erk activation may be required for the full proliferative activ-
ity of NSPCs.
Hes1 Is a Target of FGF2-FRS2a Signaling to
Maintain NSPCs in an Undifferentiated State In Vitro
The identities of the targets of the FGF-FRS2a signaling path-
way for the self-renewal of NSCs remain unknown. It is
known that the transcription factor Bmi-1 [35] and Notch sig-
naling [36] play an important role in the self-renewal of
NSCs. Hes family proteins are transcription factors down-
stream of Notch signaling [36]. We next examined whether
certain components of the Notch signaling pathway or Bmi-1
serve as targets of FGF signaling for the self-renewal of
NSCs. Quantitative real-time reverse transcription polymerase
chain reaction showed that the expression of Bmi-1, Notch1,
Notch2, Hes3,o rHes5 mRNA was not upregulated in NSPCs
in response to FGF2 stimulation (Supporting Information
Fig. 2). Interestingly, we found that the expression of Hes1
was elevated and sustained for 24 hours in response to FGF2
in NSPCs (control; Fig. 5I).
To examine whether FRS2a is involved in FGF2-induced
Hes1 expression, we knocked down the expression of Frs2a
in NSPCs. We found that expression of Hes1 mRNA was rap-
idly decreased to basal levels after 6 hours (Fig. 5I). Expres-
sion of Hes1 protein was not induced at signiﬁcant levels by
FGF2-stimulation (Fig. 5J). We next examined whether acti-
vation of Notch1 and Notch2 contributes to the FGF2-induced
Hes1 expression. We used c-secretase inhibitor DAPT, which
blocks cleavage of the cytoplasmic domain of Notch and
thereby inhibits Notch signaling. We found that treatment
with U0126, but not DAPT, inhibited the FGF2-induced
expression of Hes1 (Fig. 5K). FGF2 stimulation did not
induce activation of Notch as shown by expression of the in-
tracellular domain of Notch1 and Notch2, nor induce expres-
sion of Delta-like one (Dll1), a Notch ligand. Treatment with
U0126 did not affect Notch activity (Fig. 5K). These results
suggest that FGF2-induced expression of Hes1 is mediated by
FRS2a, and is independent of Notch signaling but dependent
on the activation of Erk.
To further examine whether the FGF2-FRS2a-Erk-Hes1
axis contributes to the self-renewal of NSCs, we expressed
Hes1 in cultured NSPCs, in which Frs2a was knocked down
or not, and examined the resulting number and size of the
FGF2-induced neurospheres. Expression of Hes1 increased
the number of FGF2-induced neurospheres in which FRS2a
was intact (Fig. 5L). Moreover, although the knocking down
of Frs2a reduced the number of FGF-induced neurospheres,
the exogenous expression of Hes1 rescued this phenotype to
some extent (Fig. 5L). In contrast, the exogenous expression
of Hes1 neither signiﬁcantly increase the size of neurospheres
in which FRS2a was intact (data not shown) nor rescue the
decreased size of the neurospheres caused by knocking down
of Frs2a (Fig. 5B and data not shown). These results suggest
that the FGF2-FRS2a-Hes1 axis promotes the self-renewal of
NSCs.
Hes1 Is a Target of FGF2-FRS2a Signaling to
Maintain NSPCs in an Undifferentiated State In Vivo
To examine whether Hes1 is a target of signaling via FRS2a
for the self-renewal of NSCs in vivo, we inhibited the expres-
sion of FRS2a in the developing cortex by shRNA for Frs2a.
We coinjected expression vectors for GFP and an shRNA for
Frs2a or control into the telencephalic lateral ventricles of
E12.5 cortex and performed in utero electroporation. Then,
embryos were sacriﬁced at E13.5 and immunostained with
antibodies against Hes1 and GFP. We found that knocking
down of Frs2a caused a decrease in expression levels of Hes1
in the cortex (Fig. 6A, 6B). We next coinjected those expres-
sion vectors with or without vectors expressing Hes1. The
knocking down of Frs2a reduced the number of cells in VZ/
SVZ (Fig. 6C, 6D). When exogenous Hes1 was coexpressed,
many control or Frs2a knocked-down cells were localized in
the VZ/SVZ region (Fig. 6C, 6D). Hence, the exogenous
expression of Hes1 increased the number of NSPCs and res-
cued the reduced NSPCs caused by the knocking down of
Frs2a in vivo. Double-immunostaining with antibodies against
GFP and TuJ1 or Musashi-1 showed that knocking down of
Frs2a increased the ratio of neurons at the expense of NSPCs
(Fig. 6E and 6F). On the other hand, when exogenous Hes1
was coexpressed, many control or Frs2a knocked-down cells
were Musashi-1-positive, suggesting that they remained undif-
ferentiated (Fig. 6E and 6F). However, exogenous Hes1
expression did not increase the number of mitotic cells that
were positive for pH3 in the VZ/SVZ region (Supporting
Information Fig. 4). These results suggest that the FRS2a-
Hes1 axis maintains undifferentiated NSPCs in vivo; however,
exogenous Hes1 expression does not signiﬁcantly promote
cell division.
To conﬁrm that the rescued cells are bona ﬁde NSCs, we
examined whether they express nestin and undergo INM in a
similar way analyzed for Figure 3. Most cells in VZ express-
ing Hes1 also expressed nestin (97.3% 6 3.5%, total 518
cells counted in 18 randomly selected areas; Fig. 7A).
Although the GFP-positive cell bodies in the S-phase were
present at the basal side of VZ, many of them were located at
the apical side in the G1 phase (Fig. 7B and 7C). Thus, these
cells appear to be bona ﬁde NSCs. It thus appears that Hes1
is a downstream target of FGF-FRS2a signaling for the self-
renewal of NSCs in vivo.
As NSCs derived from the Frs2a
2F mutant appear to have
intact self-renewing activity [22], the expression of Hes1
should be intact in NSPCs in these mutant mice. We found
that full levels of Hes1 expression were induced by FGF2
stimulation in Frs2a
2F NSPCs in vitro (Supporting Informa-
tion Fig. 5A). We also found that there was little difference
in the expression levels of Hes1 in the cortex between the
wild-type/heterozygote and the mutant (Supporting
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www.StemCells.comFigure 6. Hes1 is a target of
ﬁbroblast growth factor (FGF)-
FGF receptor substrate 2a sig-
naling for the self-renewal of
neural stem cells. (A): Vectors
expressing EGFP and shRNAs
were coinjected into the lateral
ventricles of E12.5 mouse
embryos in utero and electropo-
rated. Then, embryos were sacri-
ﬁced at E13.5 and
immunostained against Hes1
(magenta) and GFP (green). (B):
GFP-positive cells expressing
high (arrow) or low/negligible
(arrowhead) levels of Hes1 were
counted and the results are sum-
marized. In each condition,
more than 148 cells were
counted in at least ﬁve randomly
selected areas. Scale bars ¼ 50
lm. (C–F): Vectors for the
expression of GFP, Hes1, or
shRNAs were coinjected into
the lateral ventricles of E12.5
mouse embryos in utero and
electroporated. Then, the
embryos were sacriﬁced at
E15.5, and cortical sections
were immunostained against
GFP (green) (C), GFP and
Musashi-1 (magenta) ([E], upper
panel), or GFP and TuJ1 (ma-
genta) ([E], lower panel). (D,
F): Quantiﬁcation of the data in
(C) and (E), respectively. In
each condition, at least 400 cells
were counted in 8–18 randomly
selected areas. Abbreviations:
CP, cortical plate; EGFP,
Enhanced Green Fluorescent
Protein; GFP, Green Fluorescent
Protein; IZ, intermediate zone;
SVZ, subventricular zone; VZ,
ventricular zone.
Figure 5. (Overleaf) Erk activation via FRS2a is required for the FGF-induced self-renewal of neural stem cells. (A): NIH3T3 cells were infected
with retroviral vectors encoding shRNAs. The cells were then lysed and the lysates were subjected to immunoblotting. (B, C): Fibroblast growth fac-
tor 2 (FGF2)-induced secondary neurospheres infected with retrovirus encoding shRNAs were dissociated, and the cells were cultured again in the
presence of FGF2, and the diameter (B) and number (C) of the resulting tertiary neurospheres were determined. Experiments were performed four
times with similar results. (D, E): Neural stem/progenitor cells (NSPCs) infected with lentivirus encoding shRNAs were starved and then stimulated
with FGF2. Then cells were lysed, and the lysates were subjected to immunoblotting. (F): NSPCs were cultured in the presence of FGF2 together
with different doses of U0126. Then, the cells were lysed 6 or 10 hours after the initiation of culture. The relative activity of pErk against Erk1/2 is
shown in the right panel. (G, H): NSPCs were cultured in the presence of FGF2 together with U0126 to form neurospheres. The resulting primary
neurospheres were dissociated to single cells and the cell number was counted. Then, NSPCs were cultured again to form secondary neurospheres,
and the number of resulting neurospheres was determined. Data are represented as average with SD of at least three separate experiments, and the y-
axis indicates percentage to the control (0 lM). We counted at least 200 spheres in each experiment. (I, J): NSPCs infected with lentivirus were
starved and stimulated with FGF2. RNA was extracted from NSPCs for quantitative reverse transcription polymerase chain reaction (I) or NSPCs
were lysed for immunoblotting (J) at each time point. (K): NSPCs were starved and pretreated for 1 hour with DMSO (vehicle), 25 lM U0126, or
10 lM DAPT before stimulation with FGF2. Then, cells were lysed for immunoblotting. (L): NSPCs were infected with lentivirus expressing
shRNAs and retrovirus expressing Hes1 or its empty vector, and cultured in the presence of FGF2. Then, cells were passed and cultured again in the
presence of FGF2, and the number of the resulting neurospheres were determined. Experiments were performed three times with similar results.
Abbreviations: DAPT, ((N-[N-(3,5-diﬂuorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester); DMSO, dimethyl sulfoxide; FRS2a, FGF receptor sub-
strate 2a.
1668 FRS2a-Erk Axis Regulates Neural Stem CellsInformation Fig. 5B). In addition, we examined expression
levels of Hes1 in Frs2a
4F mutant cortex. As expected, we
found little difference in expression levels of Hes1 between
wild-type/heterozygote and the Frs2a
4F mutant (data not
shown). Moreover, though treatment with PD98059 moder-
ately reduced FGF2 induced-Erk activation, it did not affect
Hes1 expression (Supporting Information Fig. 5C). These
results further support the notion that Hes1 is a low level tar-
get of Erk activated by FGF-FRS2a signaling.
To examine the molecular mechanisms of Hes1 induction
by FGF-FRS2a signaling, we performed a luciferase assay
with a reporter vector containing the promoter region of Hes1
(–2570 to þ277) in cultured NSPCs. FGF2 stimulation
increased promoter activity, and this was inhibited by treat-
ment with U0126 (Supporting Information Fig. 6A). Serial de-
letion analysis of the promoter ( 750,  487, and  12)
showed that FGF2 stimulation increased the promoter activity
up to  750, but this was inhibited in  487 or  12 construct
(Supporting Information Fig. 6B). In the promoter region
between  750 to  487, we identiﬁed a potential binding
sequence of AP-1 ( 498 to  492, TGACTCC) [37], an im-
portant transcriptional activator downstream of Erk, composed
of members of Jun and Fos families [38]. Point mutations in
this sequence (TGACTCC to CGTCTAC) abolished the acti-
vation of the reporter by FGF2 stimulation (Supporting Infor-
mation Fig. 6B). The expression of c-Fos, a member of the
Fos family, was rapidly induced after FGF2 stimulation in
NSPCs (Supporting Information Fig. 6C), and chromatin
immunoprecipitation assay showed that c-Fos interacted with
the promoter region containing the putative AP-1-binding site
Figure 7. Cells expressing Hes1 show radial glial properties (A–C). (A, B): Vectors expressing Hes1, GFP, and shRNA for FRS2a were coin-
jected into the lateral ventricles of E13.5 mouse embryos in utero and electroporated. Then, the embryos were sacriﬁced at E15.5, and cortical
sections were immunostained against GFP (green) and nestin (magenta; [A]) or BrdU (magenta; [B]). BrdU was administered 30 minutes or 12
hours before sacriﬁce. (A): Most GFP-positive cells expressed nestin, as indicated by arrowheads. Scale bar ¼ 50 lm. (B): The cell bodies of
most GFP-positive cells in the S-phase (30 minutes after BrdU administration) were located at the basal half of VZ (arrowhead). In contrast, the
cell bodies of GFP-positive cells in the G1 phase were present at both the basal and apical (arrow) half of VZ. Scale bar ¼ 10 lm. (C): Quantiﬁ-
cation of the data in (B). In each condition, at least 145 cells were counted in 19–29 randomly selected areas. (D): Fibroblast growth factor
(FGF)-induced Erk activation via Shp2- or Grb2-binding sites of FRS2a contributes to both proliferation of neural stem/progenitor cells (NSPCs)
and self-renewal of neural stem cells (NSCs). The latter is at least partly mediated by Hes1, whose expression may be induced by the binding of
AP-1 complex to the Hes1 promoter. (E): For the normal proliferation of NSPCs in response to FGF, strong Erk activation via both Shp2- and
Grb2-binding sites of FRS2a is required. On the other hand, relatively weak Erk activation levels are sufﬁcient to activate the self-renewal switch
of NSCs with Hes1 expression, the master regulator for stemness. Abbreviations: BrdU, Bromodeoxyuridine; FGFR, Fibroblast growth factor re-
ceptor; FRS2a, FGF receptor substrate 2a; GFP, Green Fluorescent Protein; VZ, ventricular zone.
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6D). FGF2 stimulation transiently induced expression of c-
Fos, reaching peak levels at  80 minutes, and formation of
AP-1 complex, and then expression of c-Fos gradually
declined to basal levels. On the other hand, expression levels
of c-Jun were stable (Supporting Information Fig. 6E). More-
over, knocking down of c-Fos decreased FGF2-induced Hes1
expression (Supporting Information Fig. 6F). These results
suggest that Erk activation by FGF2 stimulation induces the
expression of c-Fos, and then, AP-1 containing c-Fos binds to
the Hes1 promoter and activates transcription.
It has been reported that expression of Hes1 oscillates in
neural progenitor cells, though precise molecular mechanisms
are still unclear. To examine whether FGF signaling is
involved in this process, we incubated cultured NSPCs in the
starvation media without growth factors for overnight, stimu-
lated them with FGF2, and monitored the expression levels of
Hes1, c-Fos, and c-Jun at every 20 minutes (Supporting Infor-
mation Fig. 6G). After starvation, expression of Hes1 was at
very low levels. Upon stimulation with FGF2, expression of
Hes1 was strongly induced, reaching a peak level after  100
minutes and declined to a basal level after  180 minutes.
Then Hes1 expression was increased again and reached the
second peak level after  240 minutes, though the expression
levels at the second peak were lower than those of the ﬁrst.
Expression of c-Fos was strongly induced by FGF2 stimula-
tion, then declined gradually to a basal level and did not
show the second peak (Supporting Information Fig. 6E and
data not shown). When c-Fos was knocked down, expression
levels of Hes1 was decreased without showing the second
peak (data not shown). We also monitored phosphorylation
levels of Erk in the same time course and found that levels of
phosphorylation of Erk was transiently induced as those of c-
Fos without showing the second peak, while expression levels
of Erk were stable (Supporting Information Fig. 6E and data
not shown). These results suggest that the FGF-AP-1 signal-
ing is important for the induction of Hes1 expression to initi-
ate oscillation in cultured NSPCs.
DISCUSSION
In this report, we dissected the role of FGF signaling for the
self-renewal and proliferation of NSPCs. First, FRS2a, a cen-
tral mediator of FGF signaling, appears to selectively activate
Erk and induces little activation of Akt. Then, it is likely that
low levels of Erk activation is sufﬁcient for induction of
Hes1, which allows NSCs to self-renew. Further, high levels
of Erk activation may be required for full levels of prolifera-
tion of NSPCs (Fig. 7D and 7E).
FRS2a Controls the FGF-Erk Axis by the Degree
of Tyrosine Phosphorylation on Grb2- and
Shp2-Binding Sites
This notion is well-supported by the phenotype of Frs2a
mutants and NSPCs expressing reduced levels of FRS2a by
the expression of shRNA for Frs2a. The Frs2a knocked-down
NSPCs showed impaired self-renewing activity with reduced
Hes1 expression and impaired proliferation. The Shp2-binding
site mutant Frs2a
2F-derived NSPCs showed intact self-renew-
ing activity with intact Hes1 expression but impaired prolifer-
ation. The Grb2-binding site mutant Frs2a
4F-derived NSPCs
showed intact self-renewing activity but slightly impaired pro-
liferation. On the other hand, FGF2-induced activation of Erk
was most impaired in the Frs2a knocked-down NSPCs among
the wild-type, Frs2a
2F, and Frs2a
4F NSPCs. We previously
reported that the Frs2a
4F mutant is able to activate Erk at
slightly higher levels than the Frs2a
2F mutant, although both
mutants show reduced levels of Erk activation than wild-type
FRS2a [13]. Therefore, it is likely that the differences in the
activities of self-renewal and proliferation of NSPCs in each
FRS2a mutant is at least partly due to different levels of Erk
activity.
In other words, we demonstrated that FRS2a controls the
FGF-Erk axis by the degree of tyrosine phosphorylation on
Grb2- and Shp2-binding sites (Fig. 7D and 7E). Low Erk acti-
vation levels via at least one of two tyrosine phosphorylation
sites of FRS2a are sufﬁcient for FGF-dependent enhancement
of Hes1 expression and self-renewal of NSCs. In contrast,
strong Erk activation via both the tyrosine phosphorylation
sites are required for the full proliferation of NSPCs.
Consistent with our results, there is a convincing evidence
that Erk2 is required for the full activity of self-renewal of
NSCs and proliferation of NSPCs in response to FGF2, based
on the studies using conditional Erk2 knockout mice [39]. It
was also reported that adhesion signals by b1 integrin partly
contributes to Erk activation for NSC maintenance [40]. Coor-
dinated signaling of both growth factors such as FGF and ad-
hesion such as b1 integrin would be essential for NSC
maintenance.
FGF-FRS2a-Erk Signaling Regulates Hes1
Expression and Self-Renewal of NSCs
It is known that Hes1 plays important roles for self-renewal
of NSCs. Hes1 knockout mice show defects in self-renewal of
NSCs [28]. In this article, the authors also showed that prolif-
eration of NSPCs is not signiﬁcantly affected in the Hes1
knockout mice. These ﬁndings are consistent with our results.
Because it has been reported that the expression level of
Hes5, but not Hes1, is reduced in Notch1 or CBF1 mutant
mice, the expression of Hes1 has been predicted to also be
regulated by signaling cascades other than Notch signaling
[36]. Our results suggest that FGF-FRS2a-Erk signaling is
indeed a distinct pathway from Notch signaling for the self-
renewal of NSCs. This notion is supported by the result that
knockdown of Frs2a led to reduced self-renewing activity of
NSCs, and the coexpression of Hes1 rescued the phenotype in
vitro and in vivo. Consistent with this, it was reported that
overexpression of Hes1 or activated forms of either Notch1 or
FGF receptor two increases the self-renewing activity of
NSCs in the cortex [23, 41, 42].
We showed that FGF activates Hes1 promoter dependent
on activation of Erk and our results suggest that the transcrip-
tion factor complex AP-1 binds to the AP-1 consensus bind-
ing site of Hes1 promoter. Therefore, it appears that FGF-Erk
axis induces expression of Hes1 at the transcriptional levels.
It is known that Hes1 expression oscillates in many cell
types, including presomitic mesoderm and many cultured
cells [43]. During mouse somitogenesis, oscillation of Hes7,
another Hes family member, is initiated by FGF signaling
and propagated or maintained by Notch signaling [44]. It
was reported that the oscillation of Notch-induced Hes1
expression regulates the maintenance of NSCs [45]. Accu-
mulating evidence indicates that negative feedback mecha-
nisms lead to oscillatory responses [46]. Hes1 serves as a
transcriptional repressor, acting in an autoregulatory loop in
the negative feedback mechanisms. Hes1 represses its own
promoter, resulting in disappearance of Hes1 mRNA and
Hes1 protein. Then the disappearance of Hes1 protein leads
to relief from the repression and allows the next round of
expression. It was recently reported that FGF induces Hes1
expression in an oscillatory manner in a mesenchymal C3H
1670 FRS2a-Erk Axis Regulates Neural Stem Cells10T1/2 cell line [47]. In these cells, Erk activation also
oscillates due to negative feedback mechanisms through Sos
protein, a Ras activator. As we did not observe oscillation
of FGF2-induced c-Fos expression or Erk activation, the au-
toregulatory loop involving Hes1 and Notch signaling might
be sufﬁcient for the Hes1 oscillation in NSPCs. Together
with our results it appears that FGF-FRS2a-Erk-AP-1 signal-
ing is important for the induction of Hes1 expression to the
levels at which oscillation takes place in NSPCs. It is possi-
ble that FGF signaling keeps basal levels of Hes1 transcrip-
tion. Nevertheless, it is possible that FGF signaling contrib-
utes to regulation of oscillation at another level. We found
that the second peak levels of Hes1 expression in FGF2-
stimulated NSPCs were greatly reduced compared with the
ﬁrst peak levels. This may be because cells were
desynchronized in the second round of Hes1 expression as
previously described in other cells [43]. Therefore, to exam-
ine the precise role of FGF signaling for Hes1 oscillation in
NSPCs, it would be important to monitor cycling activity of
Hes1 promoter in individual cells by real-time imaging as
previously reported [42, 43].
CONCLUSION
In response to FGF2, FRS2a signals increase Erk phosphoryl-
ation levels, controlled by the degree of its tyrosine phospho-
rylation. This leads to qualitatively different biological out-
puts: self-renewal at least partly mediated by Hes1, the
master regulator of stemness, versus cell proliferation. The
molecular mechanisms by which FRS2a controls NSCs could
be generalized to a variety of other stem cells. Certain meth-
ods for modifying the functions of FRS2a may be useful for
obtaining in vitro cultures of stem cells of desired quality.
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